Abstract
Bone marrow suppression due to exposure to ionizing radiation is a significant clinical problem associated with radiation therapy as well as with nonmedical radiation exposure. Currently, there are no small molecule agents available that can enhance hematopoietic regeneration after radiation exposure. Here, we report on the effective mitigation of acute hematopoietic radiation syndrome in mice by the synthetic triterpenoid, RTA 408. The administration of a brief course of RTA 408 treatment, beginning 24 h after lethal doses of radiation to bone marrow, significantly increased overall survival. Importantly, treatment with RTA 408 led to the full recovery of steady state hematopoiesis with normalization of the frequency of hematopoietic stem and progenitor cells. Moreover, hematopoietic stem cells from RTA 408-mitigated mice showed lineage-balanced, long-term, multilineage potential in serial transplantation assays, indicative of their normal self-renewal activity. The potency of RTA 408 in mitigating radiation-induced bone marrow suppression makes it an attractive candidate for potential clinical use in treating both therapy-related and unanticipated radiation exposure.
References
Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·P MauchH J Deeg
Jan 5, 2002·Blood·Marina KonoplevaMichael Andreeff
Jun 3, 2005·Cancer Research·Karen LibyMichael B Sporn
Jul 2, 2005·Cell·Mark J KielSean J Morrison
Jul 5, 2006·Molecular Cancer Therapeutics·Yan JiNanjoo Suh
Sep 26, 2006·The Journal of Biological Chemistry·Rehan AhmadDonald Kufe
Nov 14, 2006·Biochemical and Biophysical Research Communications·Rajesh K ThimmulappaShyam Biswal
Mar 24, 2007·Experimental Hematology·Nelson J Chao
Aug 3, 2007·Blood·Steffen KoschmiederDaniel G Tenen
Sep 8, 2007·Antioxidants & Redox Signaling·Rajesh K ThimmulappaShyam Biswal
Apr 17, 2008·Cancer Research·Rehan AhmadDonald Kufe
Apr 24, 2009·Carcinogenesis·Melinda S YatesThomas W Kensler
Jun 3, 2009·Stem Cells·Arthur J SimonnetDiana Tronik-Le Roux
Sep 2, 2009·Stem Cell Research·Bei LiWilliam H Fleming
Sep 3, 2009·Molecular Cancer Therapeutics·Borbala DarocziUlrich Rodeck
Sep 18, 2009·Blood·Devorah C GoldmanWilliam H Fleming
Dec 22, 2009·Current Molecular Pharmacology·Mang Xiao, Mark H Whitnall
Jul 16, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jeffery J AulettaJohn J Letterio
Nov 22, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Erik AmesWilliam J Murphy
Aug 30, 2012·Health Physics·Hui Lin ChuaChristie M Orschell
Dec 12, 2012·Antioxidants & Redox Signaling·Donna D Zhang
Oct 16, 2013·Antioxidants & Redox Signaling·Lijian ShaoDaohong Zhou
Jan 28, 2014·The Journal of Clinical Investigation·Jung-Hyun KimShyam Biswal
Mar 14, 2014·Blood·Lijian ShaoDaohong Zhou
Apr 12, 2014·Radiation Research·Scott A ReismanKeith W Ward
Citations
Jan 17, 2016·Redox Biology·Xiaobin LiuHongli Wu
Apr 14, 2016·PloS One·Jennifer F DossJen-Tsan Chi
Dec 1, 2017·Physiological Genomics·Qin M Chen, Anthony J Maltagliati
Feb 13, 2018·Oxidative Medicine and Cellular Longevity·Peng HanWei Zhang